# OnCo record ono-pharmaceutical (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/ono-pharmaceutical/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "ono-pharmaceutical" ;
  schema:name "Ono Pharmaceutical"@en ;
  schema:alternateName "ONO PHARMACEUTICAL CO., LTD."@en, "Ono Pharma"@en ;
  schema:description "Ono Pharmaceutical is an Osaka drug company that launched the immunotherapy nivolumab (Opdivo) in Japan in 2014. It bought the US company Deciphera Pharmaceuticals in 2024."@en ;
  schema:url <https://onco.cc/companies/ono-pharmaceutical/>, <https://www.ono-pharma.com/en> ;
  schema:dateModified "2026-11-03"^^xsd:date ;
  schema:citation <https://www.ono-pharma.com/en>, <https://www.ono-pharma.com/en/company/history>, <https://www.ono-pharma.com/en/company/about/office> ;
  schema:addressCountry "JP" ;
  onco:sections <https://onco.cc/fronts/immunotherapy/>, <https://onco.cc/fronts/targeted-therapy/> ;
  onco:technologies <https://onco.cc/technologies/checkpoint-inhibitor/> ;
  onco:targets <https://onco.cc/targets/pd1/> ;
  onco:drugs <https://onco.cc/drugs/nivolumab/> .